Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture - PubMed (original) (raw)
Review
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture
Andrew C Newby. Physiol Rev. 2005 Jan.
Free article
Abstract
Intimal thickening, the accumulation of cells and extracellular matrix within the inner vessel wall, is a physiological response to mechanical injury, increased wall stress, or chemical insult (e.g., atherosclerosis). If excessive, it can lead to the obstruction of blood flow and tissue ischemia. Together with expansive or constrictive remodeling, the extent of intimal expansion determines final lumen size and vessel wall thickness. Plaque rupture represents a failure of intimal remodeling, where the fibrous cap overlying an atheromatous core of lipid undergoes catastrophic mechanical breakdown. Plaque rupture promotes coronary thrombosis and myocardial infarction, the most prevalent cause of premature death in advanced societies. The matrix metalloproteinases (MMPs) can act together to degrade the major components of the vascular extracellular matrix. All cells present in the normal and diseased blood vessel wall upregulate and activate MMPs in a multistep fashion driven in part by soluble cytokines and cell-cell interactions. Activation of MMP proforms requires other MMPs or other classes of protease. MMP activation contributes to intimal growth and vessel wall remodeling in response to injury, most notably by promoting migration of vascular smooth muscle cells. A broader spectrum and/or higher level of MMP activation, especially associated with inflammation, could contribute to pathological matrix destruction and plaque rupture. Inhibiting the activity of specific MMPs or preventing their upregulation could ameliorate intimal thickening and prevent myocardial infarction.
Similar articles
- Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly.
Galis ZS, Khatri JJ. Galis ZS, et al. Circ Res. 2002 Feb 22;90(3):251-62. Circ Res. 2002. PMID: 11861412 Review. - Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates.
Newby AC. Newby AC. Cardiovasc Res. 2006 Feb 15;69(3):614-24. doi: 10.1016/j.cardiores.2005.08.002. Epub 2005 Nov 2. Cardiovasc Res. 2006. PMID: 16266693 Review. - Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
Johnson JL. Johnson JL. Expert Rev Cardiovasc Ther. 2007 Mar;5(2):265-82. doi: 10.1586/14779072.5.2.265. Expert Rev Cardiovasc Ther. 2007. PMID: 17338671 Review. - Plasmin and matrix metalloproteinases in vascular remodeling.
Lijnen HR. Lijnen HR. Thromb Haemost. 2001 Jul;86(1):324-33. Thromb Haemost. 2001. PMID: 11487021 Review. - Matrix metalloproteinases and atherogenesis in dependence of age.
Kunz J. Kunz J. Gerontology. 2007;53(2):63-73. doi: 10.1159/000096351. Epub 2006 Oct 17. Gerontology. 2007. PMID: 17047333 Review.
Cited by
- Convergence of endothelial dysfunction, inflammation and glucocorticoid resistance in depression-related cardiovascular diseases.
Hage Z, Madeira MM, Koliatsis D, Tsirka SE. Hage Z, et al. BMC Immunol. 2024 Sep 27;25(1):61. doi: 10.1186/s12865-024-00653-9. BMC Immunol. 2024. PMID: 39333855 Free PMC article. Review. - SRF SUMOylation modulates smooth muscle phenotypic switch and vascular remodeling.
Xu Y, Zhang H, Chen Y, Pober JS, Zhou M, Zhou JH, Min W. Xu Y, et al. Nat Commun. 2024 Aug 13;15(1):6919. doi: 10.1038/s41467-024-51350-5. Nat Commun. 2024. PMID: 39134547 Free PMC article. - Long-term ambient air pollution exposure and renal function and biomarkers of renal disease.
Kilbo Edlund K, Xu Y, Andersson EM, Christensson A, Dehlin M, Forsblad-d'Elia H, Harari F, Ljunggren S, Molnár P, Oudin A, Svartengren M, Ljungman P, Stockfelt L. Kilbo Edlund K, et al. Environ Health. 2024 Aug 9;23(1):67. doi: 10.1186/s12940-024-01108-9. Environ Health. 2024. PMID: 39123230 Free PMC article. - Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets.
Chen R, Zhang H, Tang B, Luo Y, Yang Y, Zhong X, Chen S, Xu X, Huang S, Liu C. Chen R, et al. Signal Transduct Target Ther. 2024 May 31;9(1):130. doi: 10.1038/s41392-024-01840-1. Signal Transduct Target Ther. 2024. PMID: 38816371 Free PMC article. Review. - Circulatory endostatin level and risk of cardiovascular events in patients with end-stage renal disease on hemodialysis.
Kim JS, Kim M, Jeong KH, Moon JY, Lee SH, Ko GJ, Lee DY, Lee SY, Kim YG, Hwang HS. Kim JS, et al. Kidney Res Clin Pract. 2024 Mar;43(2):226-235. doi: 10.23876/j.krcp.22.227. Epub 2024 Mar 13. Kidney Res Clin Pract. 2024. PMID: 38600030 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous